cro.directory
← Compare landing

Cellentia, Inc. vs Cyagen Biosciences

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cellentiabio/cyagen

CategoryCellentia, Inc.Cyagen Biosciences
Listed sitecrocro
SummarySpecialized contract research organization offering custom bioassays, organoid culturing, AAV and MSD assays, PBMC isolation, and patient-derived 3D tumor organoid lines for drug development and translational research.Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical drug discovery, with specialized platforms including HUGO-GT™ and HUGO-Ab™ for humanized target validation and antibody screening.
Services
  • Translational Research
  • Biomarker Assays
  • In Vitro Pharmacology
  • Specialized & Large-Animal Models
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Translational Research
  • Immunology & Inflammation Services
  • Virology Services
Modalities
  • AAV / Viral Vector Platform
  • Cell Therapy
  • Biologics (Monoclonal Antibodies)
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Indications
  • Oncology
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Ophthalmology
Locations
  • Headquarters, Mountain View, CA, USA
  • Headquarters, Mountain View, California, United States
  • Headquarters, Santa Clara, California, United States
CertificationsData not yet provided.
  • AAALAC International · Identifier: AAALAC-accredited facilities
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.